Ceramide and Insulin Resistance: How Should the Issue Be Approached?
Author:
Open Access
- 15 November 2012
- journal article
- editorial
- Published by American Diabetes Association in Diabetes
- Vol. 61 (12) , 3081-3083
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Ceramide kinase deficiency improves diet‐induced obesity and insulin resistanceFEBS Letters, 2012
- Targeting Ceramide Synthesis to Reverse Insulin ResistanceDiabetes, 2010
- Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen ConsumptionDiabetes, 2010
- An Overview of Sphingolipid Metabolism: From Synthesis to Breakdown2010
- Glycosphingolipids and insulin resistanceProgress in Lipid Research, 2009
- The Role of Skeletal Muscle Sphingolipids in the Development of Insulin ResistanceThe Review of Diabetic Studies, 2008
- Ceramides in insulin resistance and lipotoxicityProgress in Lipid Research, 2006
- Relationship Between Insulin Sensitivity and Sphingomyelin Signaling Pathway in Human Skeletal MuscleDiabetes, 2004
- Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exerciseAmerican Journal of Physiology-Endocrinology and Metabolism, 2002
- The role of sphingolipids in the process of signal transductionProgress in Lipid Research, 1997